AGORACOM-JC « AGORACOM Small-cap Investor Relations Blog

Author Archive

Loop Insights $MTRX.ca $RACMF Selected to Join Impact Radius Marketplace to Connect Leading Global Brands With Insights Customers and Build Additional Revenue Streams $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:18 AM on Wednesday, November 18th, 2020

https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Announced the Company has been selected to join the Impact Radius Marketplace
Impact is the global leader in Partnership Automation and catalyst for the new Partnership Economy
Impact accelerates enterprise growth by automating the full partnership lifecycle for enterprise partnerships, with its Partnership Cloud™ managing over $50B in e-commerce sales and processing over $2B per year in payments to partners
Provides Loop with the opportunity to connect with and leverage marketing opportunities with Impact global brand partners such as Fanatics, Uber, Nike, Adidas, Airbnb, Levi’s and many more

VANCOUVER, British Columbia, Nov. 18, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space, is pleased to announce the Company has been selected to join the Impact Radius Marketplace (“Impact”), providing Loop with the opportunity to connect with and leverage marketing opportunities with Impact global brand partners such as Fanatics, Uber, Nike, Adidas, Airbnb, Levi’s and many more.

IMPACT RADIUS IS THE GLOBAL LEADER IN PARTNERSHIP AUTOMATION MANAGING OVER $50 BILLION IN E-COMMERCE SALES

Impact is the global leader in Partnership Automation and catalyst for the new Partnership Economy. Impact accelerates enterprise growth by automating the full partnership lifecycle for enterprise partnerships, with its Partnership Cloud™ managing over $50B in e-commerce sales and processing over $2B per year in payments to partners.

As a result of its enterprise focus, Impact follows a rigorous selection process. In evaluating and eventually selecting Loop, Impact assessed both the opportunity Loop could provide brand partners with millions of potential users, as well as, the data Loop could provide to brands and the ability to deliver real-time activations to sports fans both at venues and at home.

Loop Insights CEO Rob Anson stated : “Selection into the Impact Radius marketplace is another strong vote of confidence for Loop as we continue to grow our client base. The Impact Radius marketplace will provide Loop with access to leading brands from around the world who will be discovering our anticipated massive venue audiences, AI analytics, real-time engagement, and verified reviews for the very first time. We look forward to providing these brands with never before seen opportunities to create new revenue streams with Loop.”

PAVING THE LAST MILE TO THE CUSTOMER IS THE NEXT STAGE OF ENTERPRISE GROWTH

A commissioned study conducted by Forrester Consulting in 2020 on behalf of Impact Radius determined that companies with well-developed partnership programs grow faster and outperform their low-maturity peers on a number of key business metrics.

Specifically, clients of Impact are generating up to 25% of total enterprise revenue through partnerships, with partnership revenue as a channel growing by 50% or more year over year.

“With over 75% of world trade flowing indirectly, Forrester believes the third stage of enterprise growth will revolve around paving the last mile to the customer through partners and alliances.” (Jay McBain, Forrester, Principal Analyst Global Channels)

LOOP POSITIONED TO DRIVE AFFILIATE MARKETING OPPORTUNITIES, NEW REVENUE STREAMS THROUGH RETAIL INSIGHTS AND ENGAGEMENT PLATFORM

Through its AI-driven retail analytics and insights platform, Loop Insights is positioning itself to become a significant player in the e-commerce and affiliate marketing space. Placement in the Impact Radius marketplace will allow Loop to generate revenue through global brand affiliate marketing programs delivered directly to consumers through the Company’s Wallet pass technology.

By enabling direct-to-consumer (DTC) brand affiliate relationships, Loop will provide brands with new targeted marketing opportunities through AI-driven analytics and insights. The Company expects to generate high conversion rates for brands through its retail insights platform, which will drive brand engagement, clicks, and sales while also generating revenue for Loop, which receives up to 10% per retail transaction.

As announced in a press release dated November 12, 2020, Loop Insights’ Uklipz platform will allow the Company to provide additional marketing opportunities to Impact Radius clients through verified video reviews created by consumers. The reviews can then be purchased or analyzed by brands and retailers to drive further engagement and sales.

The Company is exceptionally confident our complete solution from DTC access to AI analytics to verified reviews will provide Impact global brand customers with a compelling new channel.

LOOP SELECTION TO IMPACT MARKETPLACE DELIVERS SIGNIFICANT VALUE TO CURRENT AND PROSPECTIVE CLIENTS

Moreover, Loop’s inclusion in the Impact Radius marketplace will deliver significant value to our own clients through optimized marketing opportunities. By gaining access to the Impact Radius marketplace, Loop will advance revenue-generating opportunities for both the Company and its expanding list of clients. Loop’s retail engagement platform offers direct 1:1 marketing opportunities to brands, providing both Loop and its client base with additional revenue streams at each purchase point.

Loop is set to showcase its affiliate marketing integration with its Engage service during the NCAA #BeachBubble in Fort Myers, Florida. Attendees using their All Access Wallet Pass for venue tracing will also receive personalized discounts and promotions tailored to the event. This will combine the safety and security of end-to-end rapid testing and notifications with enhanced personalized user engagement demonstrating Loop’s full solution stack during a live event.

According to TrueList, more than 80% of brands offer affiliate marketing programs today, with Affiliate Marketing responsible for 16% of global e-commerce sales.

According to Statista, affiliate marketing just in the USA is expected to generate almost $USD 9 Billion by 2022.

This press release is available on the Loop Insights Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/LoopInsights

About Impact Radius

Impact is the global leader in Partnership Automation and catalyst for the new Partnership Economy. Impact accelerates enterprise growth by automating the full partnership lifecycle, including discovery, recruitment, contracting, engagement, fraud protection, optimization, and payment processing for enterprise partnerships. Impact’s Partnership Cloud™ manages over $50B in e-commerce sales and processes over $2B per year in payments to partners. Impact drives revenue growth for global enterprise brands such as Bass Pro Shops, Fanatics, Getty Images, Lenovo, Levi’s, Techstyle, and Ticketmaster. Founded in Santa Barbara, CA in 2008, Impact has grown to over 500 employees worldwide.

About Loop Insights

Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.

For more information, please contact:
Loop Insights Inc.	LOOP Website : www.loopinsights.ai
Rob Anson , CEO	Facebook: @LoopInsights
T : +1 877-754-5336 Ext. 4	Twitter: @LoopInsights
E : [email protected]	LinkedIn: @LoopInsights

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: AI, Amazon, artificial intelligence, Big data, covid19, Covid19 tracing, CSE, Fobi, internet of things, mCloud Technologies Corp, Nexoptic Technology Corp, Quisitive Technology Solutions Inc., SG-retail, Shoptalk
Posted in All Recent Posts, Featured, Loop Insights Inc. | Comments Off on Loop Insights $MTRX.ca $RACMF Selected to Join Impact Radius Marketplace to Connect Leading Global Brands With Insights Customers and Build Additional Revenue Streams $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Binovi $VISN.ca $BNVIF Closes Private Placement of $2.05 Million $EYPT $KALA $PTON

Posted by AGORACOM-JC at 6:45 PM on Tuesday, November 17th, 2020

http://www.smallcapepicenter.com/binovi%20square.png

Closed its previously announced non-brokered private placement financing for gross proceeds of $2,050,000
The Company issued a total of 16,078,431 units at $0.1275 per unit, with each unit comprised of one common share of the Company and one common share purchase warrant

TORONTO, ON and NEW YORK, NY / November 17, 2020 / Binovi Technologies Corp., (Binovi) (TSXV:VISN)(OTCQB:BNVIF), a leader in neuro-vision performance technology, is pleased to announce it has closed its previously announced non-brokered private placement financing for gross proceeds of $2,050,000 (the “Private Placement”). The Company issued a total of 16,078,431 units at $0.1275 per unit, with each unit comprised of one common share of the Company (a “Share”) and one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Share (each, a “Warrant Share”) at an exercise price of $0.40 per Warrant Share at any time until November 16, 2022. The warrants are subject to an acceleration clause whereby if the common share price is equal to or greater than $0.45 for a period of 5 consecutive trading days (at any time at or following the expiry of the four months resale restriction period), the Company may, by notice to the warrant holder reduce the remaining exercise period applicable to the warrants to not less than 30 days from the date of such notice.

The Company paid aggregate finder’s fees of $21,274.65 in cash and 166,860 finder’s warrants, with each finder warrant having the same terms as the Warrants.

The securities issued in connection with the Private Placement are subject to a four-month hold period expiring on March 18, 2021. Further restrictions may apply to certain subscribers under foreign securities laws.

Insiders participated in the Private Placement acquiring an aggregate of 2,284,314 units on the same basis as other subscribers. The participation in the Private Placement by insiders of the Company constitutes a “related party transaction” as such term is defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The Company is relying on exemptions from the formal valuation and minority approval requirements under MI 61-101. The Company relied on Section 5.5(a) of MI 61-101 for an exemption from the formal valuation requirement and Section 5.7(1)(a) of MI 61-101 for an exemption from the minority shareholder approval requirement of MI 61-101 as the fair market value of the private placement in so far as the private placement involved interested parties did not exceed 25% of the Company’s market capitalization.

The Company intends to use the net proceeds from the Private Placement for general working capital.

For additional information on the Company, please visit https://www.binovi.com/investor-reports/

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 20 countries.

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO

Investor Relations
Email: [email protected]
Toll-free: 1 (844) 866-6162

https://www.binovi.com/investor-reports/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: Binovi Touch, CSE, Eli Wilson. Eye therapy, eye training, neuro-visual performance, tsx, tsx-v, Vision Care Specialists, vision therapy
Posted in Binovi Technologies Corp. | Comments Off on Binovi $VISN.ca $BNVIF Closes Private Placement of $2.05 Million $EYPT $KALA $PTON

CLIENT FEATURE: Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Technology To Detect #COVID-19 In The Air $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 2:25 PM on Tuesday, November 17th, 2020

Kontrol Energy is the Google NEST of smart building technology, with a Blue Chip client base to prove it with the likes of Beyond Meat, Toyota, Oxford, Telus and Brookfield to name a few.

As a result, Kontrol is already achieving commercial success as follows:

Q1 $2.3M
Q2 $2.7M

TOTAL Q1 AND Q2

REVENUE $5M
GROSS PROFIT $2.7M

ADAPTING CORE TECH TO PROVIDE BLUE CHIP CUSTOMERS WITH REAL-TIME AIR DETECTION OF COVID-19 IN COMMERCIAL BUILDINGS

As a result of the COVID-19 pandemic and the needs of its blue chip customer base, Kontrol is adapting its core technologies team to development and commercialize its Kontrol BioCloud® analyzer, a wall-mounted technology which detects the presence of COVID-19 in the air of commercial buildings and triggers an alert system to provide real time notifications.

GEARING UP PRODUCTION FOR UP TO 20,000 UNITS PER MONTH

Initial expectations, based on lab testing completed to date, is that BioCloud will be effective in small to medium space settings with 3 or more people, and therefore would be suitable for areas such as classrooms, offices, airplanes, trains, buses, long-term care facilities and hospitals. The company is currently building a global supply chain with the goal of being able to supply 20,000 units per month.

The implications of the Kontrol BioCloud® analyzer could be enormous and could have a major impact on the global economy. Paul Ghezzi, CEO of Kontrol Energy has received calls from interested parties spanning the entire globe. In addition, mainstream media has taken notice:

Early tests suggest new Canadian technology could detect the coronavirus in the air Read More

Canadian firm develops tech to ‘detect COVID-19 in the air’; stock doubles Read More.

Kontrol Energy’s BioCloud Featured By Singapore’s IBI Times Read More

CSA APPROVAL RECEIVED ON NOVEMBER 5TH

On Novebmer 5th, KNR announced receipt of CSA standards approval for its BioCloud® technology.

“This is another important milestone for Kontrol and represents the continuing advancement of the BioCloud® technology,” says Paul Ghezzi, CEO Kontrol. “CSA is a Canadian standard for safety and is also accepted in jurisdictions outside Canada. In addition to CSA we continue to work on other important regional certifications including UL and CE for the United States and European markets respectively.”

UL STANDARDS APPROVAL RECEIVED NOVEMBER 12TH

“We continue to execute on the important milestones for commercialization of BioCloud,” says Paul Ghezzi, CEO of Kontrol. “With CSA and UL we now have standards approval that covers Canada, the United States and various other global regions. We continue to work towards CE standards certification which is primarily for the European market.”

DISCLAIMER: The Company has not made any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

For more information about the company, please check out the Kontrol Energy hub on AGORACOM.

FULL DISCLOSURE: Kontrol Energy is an advertising client of AGORA Internet Relations Corp.

Tags: BioCloud, COVID-19, CSA, CSA Standards, CSE, energy conservation, google nest, small cap, small cap stocks, stocks
Posted in All Recent Posts, Featured, Kontrol Energy Corp. | Comments Off on CLIENT FEATURE: Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Technology To Detect #COVID-19 In The Air $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Binovi $VISN.ca $BNVIF Appoints Dr. Susan Barry to the Binovi Scientific Advisory Board $EYPT $KALA $PTON

Posted by AGORACOM-JC at 9:39 AM on Tuesday, November 17th, 2020

Announced the appointment of Dr. Susan Barry to the Binovi Scientific Advisory Board. Dr. Barry joins the other members of the board in directing the company’s advancements
“Dr. Barry’s experiences as a patient of vision therapy have informed her extensive career and we hope to gain from her perspective on both sides of the vision care coin. Her work in the neurological examination of vision will prove incredibly valuable in our pursuit of further testing and treatment options for students and patients young and old,” commented Adam Cegielski, President and CEO.

November 17, 2020 Toronto, New York – Binovi Technologies Corp., (Binovi) (TSXV:VISN ) ( OTC:BNVIF) is proud to announce the appointment of Dr. Susan Barry to the Binovi Scientific Advisory Board. Dr. Barry joins the other members of the board in directing the company’s advancements.

“Dr. Barry’s experiences as a patient of vision therapy have informed her extensive career and we hope to gain from her perspective on both sides of the vision care coin. Her work in the neurological examination of vision will prove incredibly valuable in our pursuit of further testing and treatment options for students and patients young and old,” commented Adam Cegielski, President and CEO.

“It is a distinct privilege to have Dr. Barry join our Scientific Advisory Board,” said Dr. Leonard Press, Chief Scientific Officer. “Her unique blend of insights and communication skills that crosses many lines between educators, eyecare professionals, researchers and the public is a tremendous asset to Binovi.”

” Children struggling in school, adults recovering from a stroke, and athletes seeking to improve their game may all benefit from vision therapy. Its effects are often life-changing. I am looking forward to working with the Binovi team to develop new training techniques, explore the science behind vision therapy, and make vision therapy more accessible worldwide,” commented Dr. Susan R Barry, Ph.D.

About Dr. Susan Barry

Susan R. Barry, Ph.D. is an educator, scientist, and author who has spoken worldwide on the topics of neuroplasticity and binocular vision. She earned her B.A. in biology from Wesleyan University in 1976 and Ph.D. in biology from Princeton University in 1981. She has worked as a research neuroscientist at the University of Miami Medical School, the University of Michigan, the Marine Biological Laboratory, and NASA’s Johnson Space Center and published papers on synaptic transmission and eye-head-hand coordination. In 1992, she joined the faculty of Mount Holyoke College where she rose to the rank of full professor, retiring from the college in 2016. The Princeton Review lists Barry among the 300 outstanding college teachers in the U.S., her paper on the work of Frederick W. Brock was selected as the best published paper in the Journal of Behavioral Optometry in 2011, and in 2013 she received the Meribeth E. Cameron Faculty Award for Scholarship from Mount Holyoke College.

For years, Barry taught her neurobiology students the conventional scientific wisdom that stereovision could develop only during a critical period in early childhood. She even used her own vision history to support this dogma since she had been cross-eyed since early infancy and was stereoblind. However, at age forty-eight, she consulted a developmental optometrist who prescribed a program of optometric vision therapy. To her utter astonishment, her vision improved dramatically, and she experienced her first 3D views. Dubbed “Stereo Sue” by Oliver Sacks in a 2006 New Yorker article by that name, Dr. Barry has gone on to write her own book Fixing My Gaze: A Scientist’s Journey into Seeing in Three Dimensions (Basic Books, 2009) which was rated the fourth best science book for 2009 by the editors of Amazon.com, selected as one of the best sci-tech books of 2009 by the Library Journal, and has been translated into seven languages. Barry’s second book, Coming to Our Senses: A Boy Who Learned to See, A Girl Who Learned to Hear, and How We All Discover the World , will be published by Basic Books in the summer of 2021.

For additional information on the Company, please visit https://www.binovi.com/investor-reports

About Binovi Technologies Corp.

Binovi is a best-in-class neuro-visual platform designed to test, analyze, track, and report on individual vision and cognitive performance. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Sports Performance testing and training, and other areas of specialized care. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. Binovi is currently used in over 1,500 locations across 20 countries.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.binovi.com/investor-reports/

Forward looking information:

Tags: Binovi Touch, CSE, Eli Wilson. Eye therapy, eye training, neuro-visual performance, tsx, tsx-v, Vision Care Specialists, vision therapy, vision training
Posted in Binovi Technologies Corp. | Comments Off on Binovi $VISN.ca $BNVIF Appoints Dr. Susan Barry to the Binovi Scientific Advisory Board $EYPT $KALA $PTON

AGORACOM Small Cap 60: Else Nutrition $BABY.ca $BABYF First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping, Including a Soon-To-Be Announced, National Major Grocery Chain $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 8:39 AM on Tuesday, November 17th, 2020

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

KeHE is one of the largest and most well regarded national fresh, natural and organic and specialty food distributors in North America. Else and KeHE have activated five distribution centers in various regions across the U.S. This distribution will enable Else’s first product to be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

Tags: Amazon, baby food, Bristol-Myers Squibb Co, ConAgra Brands, CSE, gut health, investing, organic, small cap
Posted in AGORACOM Small Cap 60, Else Nutrition Holdings Inc., Featured | Comments Off on AGORACOM Small Cap 60: Else Nutrition $BABY.ca $BABYF First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping, Including a Soon-To-Be Announced, National Major Grocery Chain $BYND $VERY.ca $INGR $VEGN $TOFB

EVENT: CSE Presents Tech Tuesdays: Israeli Technology Advancements Featuring InnoCan Pharma $INNO.ca $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 7:37 AM on Tuesday, November 17th, 2020

Don’t Miss Tech Tuesdays: Israeli Technology Advancements

The CSE looks forward to co-hosting our next Tech Tuesdays showcase, Israeli Technology Advancements, with the Canada Israel Chamber of Commerce.

Join us live on November 17th!

Check out the exciting list of featured speakers!

Elad Barkan, CTO of Cannibble FoodTech Ltd.
Anna Ettedgui, Head of Funding at Blender
Iris Bincovich, CEO of InnoCan Pharma Corp. (CSE:INNO)

Don’t miss out on this exclusive glimpse at the cutting-edge technologies hailing from Israel that are making waves internationally.

Tags: CBD Derma Cosmetics, CBD stocks, CSE, Facial Serum, Innocan, Khiron Life Sciences Corp, Ovation Science Inc., Relief & Go Pain Relief Spray, SHIR, Skin care
Posted in Innocan Pharma Corporation | Comments Off on EVENT: CSE Presents Tech Tuesdays: Israeli Technology Advancements Featuring InnoCan Pharma $INNO.ca $CGC.ca $APHA $OVAT.ca $KHRN.ca

Else Nutrition $BABY.ca $BABYF Commences First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 7:28 AM on Tuesday, November 17th, 2020

Novel, Plant-based Complete Nutrition for Toddlers to hit retail shelves in coming weeks
Now commenced shipping its Plant-Based Complete Nutrition for Toddlers to retail stores across the U.S..
The Company and its distribution partner, KeHE Distributors, has thus far activated five distribution centers in various regions across the U.S.
This distribution will enable Else’s first product to very quickly be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

VANCOUVER, BC , Nov. 17, 2020 ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company , is pleased to announce that as part of its mission to ensure its novel, plant-based toddler nutrition products will be accessible to health conscious families across North America , that it has now commenced shipping its Plant-Based Complete Nutrition for Toddlers to retail stores across the U.S.. The Company and its distribution partner, KeHE Distributors, has thus far activated five distribution centers in various regions across the U.S. This distribution will enable Else’s first product to very quickly be on the shelves of numerous U.S. retail stores, including a soon-to-be announced, national major grocery chain.

“We are so pleased that Else will be available to consumers on their favourite store shelves in advance of the Christmas holiday,” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else. “We are making strong headway now, adding brick and mortar as a core sales vertical, to be complemented by our already-growing e-commerce and Amazon business verticals. We continue to extend our appreciation to KeHE Distributors for its early support of our brand, and anticipate early success and aggressive listings in 2021, as we develop our core retail accounts,” she added.

KeHE Distributors has nearly 70 years of experience servicing store owners and today has a network of over 16 distribution centers across North America . KeHE is one of the largest and most well regarded national fresh, natural and organic and specialty food distributors in North America . Else Nutrition’s agreement with KeHE Distributors secures a retail distribution path of Else’s ground-breaking plant-based toddler nutrition products to thousands of store shelves in the United States , and millions of consumers seeking plant-based alternatives for their children.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Tags: Amazon, baby food, Bristol-Myers Squibb Co, ConAgra Brands, CSE, gut health, investing, organic, small cap, stocks
Posted in All Recent Posts, Else Nutrition Holdings Inc., Featured | Comments Off on Else Nutrition $BABY.ca $BABYF Commences First Shipment to U.S. Retailers in Time for Christmas and Holiday Shopping $BYND $VERY.ca $INGR $VEGN $TOFB

AGORACOM Small Cap 60: Avicanna $AVCN.ca $AVCNF Medical #Cannabis Trusted By Physicians and Clinicians $TRUL.ca $ACB

Posted by AGORACOM-JC at 3:06 PM on Monday, November 16th, 2020

http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

Aras Azadian Chief Executive Officer and Co-Founder of Avicanna discusses the company’s medical cannabis which is trusted by physicians and clinicians. Azadian states, “Only 5% of physicians are currently prescribing Cannabis.” He continues to explain that the medical community has been skeptical of Canadian Licensed producers. Avicanna provides medical and only medical, this bodes well with the medical community.

Tags: cannabinoids, Cannabis cultivation, CBD, CSE, Marijuana, Medical Cannabis by Shoppers, Rho Phyto, stocks, Trulieve Cannabis Corp., tsx, tsx-v
Posted in AGORACOM Small Cap 60, Avicanna Inc. | Comments Off on AGORACOM Small Cap 60: Avicanna $AVCN.ca $AVCNF Medical #Cannabis Trusted By Physicians and Clinicians $TRUL.ca $ACB

Strapped In, and Fired Up: $TGS.ca and Crimson Wings to host Women’s Car Ball Championship $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 9:15 AM on Monday, November 16th, 2020

TGS Esports Announces Intent to Acquire Canadian Esports and Digital Media Startup, Volcanic Media

TGS Esports Inc. (TSXV: TGS) has teamed up with Crimson Wings to host the 3rd season of the Women’s Car Ball Championship, the world’s premier Rocket League tournament explicitly held for women
The WCBC is an amazing showcase of women’s esports talent, and we’re helping to make it bigger and more exciting than ever,” said Spiro Khouri , founder and CEO of TGS Esports. “This is going to be an exciting partnership – tons of action, tons of fun, and some of the best casters and hosts around.”

VANCOUVER, BC , Nov. 16, 2020 – Put on your driving gloves, top off the tank, and get ready to experience the utter joy of Rocket League. TGS Esports Inc. ( “TGS” or the ” Company” ) (TSXV: TGS) has teamed up with Crimson Wings to host the 3rd season of the Women’s Car Ball Championship, the world’s premier Rocket League tournament explicitly held for women.

“The WCBC is an amazing showcase of women’s esports talent, and we’re helping to make it bigger and more exciting than ever,” said Spiro Khouri , founder and CEO of TGS Esports. “This is going to be an exciting partnership – tons of action, tons of fun, and some of the best casters and hosts around.”

On November 12 , the WCBC officially announced Season 3 which will kick off December 12 . This season features a partnership with Rocket League developer Psyonix who is already showing support by sharing the news of Season 3 among their network.

The 2020 WCBC features divisions in Europe and North America , pitting teams of three in a round-robin style tournament starting in December. The total prize pool for this season is $10,000 . Jeff “Hunted” Lowe will host the event. Casters include Deep “RJsaurus” Nadar, Andrew “Squidd” Riffe , Layla “TamashiiKanjou” Abbott, and more.

“In its first year of existence, WCBC has given women a solid footing in the world of competitive rocket league, and some tier-one esports organizations use it to scout talent and plan for their future,” said Chase “Kilk” Mitchell , founder and CEO of Crimson Wings Entertainment. “This season, we’re better and stronger than ever, and we’re so excited.”

As part of the kick off for the upcoming 3 rd season TGS and Crimson Wings will be holding two open tournaments for any female Rocket League teams. November 28 th will be open to any teams in Europe while December 5 th will be for North American based teams. Both open events will have a cash prize. More info is available at www.thegamingstadium.com .

“Women are a large and often overlooked segment of the esports community,” Khouri said. “Hosting the WCBC allows us to continue to support these players and to introduce our brand to new competitors.”

For more information, please visit www.thegamingstadium.com or discord.gg/tgs .

Corporate Update
Further to its news release of November 2, 2020 , the Company has agreed to pay a finder’s fee to Jameel Bharmal in connection with the proposed acquisition of Pepper Esports Inc. by the Company (the ” Acquisition “), subject to the approval of the TSXV. The finder’s fee is payable by the issuance of 3,870,968 warrants to purchase common shares of TGS at a price of $0.155 for a period of two years following closing of the Acquisition.

About TGS Esports Inc.
TGS Esports Inc. is an organization focused on creating the ultimate esports experience. TGS is made up of industry professionals with 20+ combined years in the space of tournament organization, league facilitation, and production. This experience combined with the proposed acquisition of Pepper Esports Inc. ( https://www.newswire.ca/news-releases/tgs-esports-announces-signing-of-definitive-agreement-to-acquire-leading-competitive-esports-platform-pepper-esports-804515174.html ) allows TGS to offer a full suite of tools needed for any player or tournament organizer in esports. TGS is also the owner of Canada’s first dedicated esports arena, The Gaming Stadium, located in Richmond, British Columbia , which opened in June 2019.

On behalf of the Board of Directors
” Spiro Khouri “
Spiro Khouri , CEO
TGS Esports Inc.

Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including with respect to: the hosting of the Women’s Car Ball Championship tournament; the timing, format and prizes for the tournament; and the proposed acquisition of Pepper Esports Inc. and the finder’s fee payable in connection therewith. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. The risks include the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic and other risks that are customary to transactions of this nature. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them.

This press release is not an offer of the securities for sale in the United States . The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.

View original content to download multimedia: http://www.prnewswire.com/news-releases/strapped-in-and-fired-up-tgs-and-crimson-wings-to-host-womens-car-ball-championship-301173096.html

SOURCE TGS Esports Inc

Tags: Activision Blizzard, Allied Esports Entertainment Inc, Apple, Bragg Gaming Group Inc, Draftkings Inc, EA sports, eGambling, egaming, Enthusiast Gaming Holdings Inc, Fandom Sports Media Corp, stocks
Posted in All Recent Posts, Featured, TGS ESports Inc. | Comments Off on Strapped In, and Fired Up: $TGS.ca and Crimson Wings to host Women’s Car Ball Championship $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Innocan $INNO.ca Moves to an Advanced Efficacy Trial on Animals of Its Liposome-CBD Injection, Following Encouraging Results on the First Stage $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 7:58 AM on Monday, November 16th, 2020

Announced today the launch of two therapeutic studies on small and large animals examining the therapeutic efficacy of Innocan’s CBD loaded liposome platform technology (“LPT”) in relevant diseases
These studies follow the results of previous studies which demonstrated the prolonged release of Cannabidiol for at least 3 weeks into the blood of mice and rats after a single injection
The new studies will be conducted by the Hebrew University of Jerusalem

Herzliya, Israel and Calgary, Alberta–(November 16, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce today the launch of two therapeutic studies on small and large animals examining the therapeutic efficacy of Innocan’s CBD loaded liposome platform technology (“LPT”) in relevant diseases. These studies follow the results of previous studies which demonstrated the prolonged release of Cannabidiol for at least 3 weeks into the blood of mice and rats after a single injection. The new studies will be conducted by the Hebrew University of Jerusalem.

The original study which was led by Dr. Ahuva Cern, Senior Researcher in the lab of Prof. Barenholz at the Hebrew University in Jerusalem found significant amounts of CBD in mices’ blood and muscles up to 21 days after they were injected intramuscular with a single injection of CBD using LPT. The same findings were also demonstrated in rats.

These results are substantial when compared to oral or smoking administration of CBD, in which CBD was found in the blood only for a period of up to 36 hours after one administration.

The results of this study may indicate that Innocan’s LPT, with an injection only once or twice a month, may relieve pain or other symptoms when using CBD. These results may open the door for future experiments to prove a lack of toxicity and therapeutic efficacy of this formulation.

Innocan Israel, a wholly owned subsidiary of Innocan, has entered into a worldwide exclusive research and license agreement with Yissum Research and Development Company (“Yissum“), the commercial arm of the Hebrew University of Jerusalem in Israel, in respect of the design, preparation, characterization and evaluation of hydrogels containing CBD (or other cannabinoid) loaded liposomes. The development is led by Prof. Chezy Barenholz, head of the Membrane and Liposome department at the Hebrew University, who invented over 55 patent families, two of which underlie Doxil – the first FDA approved nano-drug aim for cancer treatment. This LPT unique technology platform may be effective for several applications (such as epilepsy, pain relief, and different inflammation and central nervous system disorders). A patent was filed by Innocan Israel on the LPT technology on October 7, 2019.

Prof. Chezy Berenholz, head of the Laboratory of Membrane and Liposome Research of the Hebrew University stated: ” I believe that these additional animal and efficacy studies are extremely important and may result in a major milestone. This may open a wide range of clinical applications, while maintaining the CBD level in the blood for a long period of time which may lead to better patient compliance. If successful, the technology may be beneficial for various indications”.

About Innocan

The Company, is a pharmaceutical tech company that focuses on the development of several drug delivery platforms containing CBD. Innocan Israel and Ramot at Tel Aviv University, are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem, to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. Innocan Israel plans, together with Professor Berenholz Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. Innocan Israel is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for the relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan Israel have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Tags: CBD Derma Cosmetics, CBD stocks, CSE, Facial Serum, Innocan, Khiron Life Sciences Corp, Ovation Science Inc., Relief & Go Pain Relief Spray, SHIR, Skin care, small cap
Posted in Featured, Innocan Pharma Corporation | Comments Off on Innocan $INNO.ca Moves to an Advanced Efficacy Trial on Animals of Its Liposome-CBD Injection, Following Encouraging Results on the First Stage $CGC.ca $APHA $OVAT.ca $KHRN.ca

Author Archive

Don’t Miss Tech Tuesdays: Israeli Technology Advancements

Check out the exciting list of featured speakers!

Categories